The Compounding Facility offers Sinus Therapy solutions to those patients who require more customized sinus care. Our success is coupled by the dynamic relationship between the doctor, patient and our lab to provide an easy therapeutic regimen. Our seasoned pharmacists can compound customized antibiotic, antifungal, anti-Inflammatory, steroidal and antihistamines medications formulated specifically to treat sinus infections and other problems. Often, multiple drugs can be delivered concurrently which is advantageous for the patient by reducing the time for therapy and the amount of total fluid delivered. All active ingredients are compounded with a cutting edge powder base, Loxasperse®. LoxaSperse® is an innovative powder excipient base created for compounding with active ingredients used for nasal sprays and irrigations. LoxaSperse® is a proprietary blend of specially micronized xylitol with an optimized ratio of micronized poloxamers, designed to improve dispersability and solubility of actives. These unique features allow multiple active ingredients with varying solubilities to be incorporated into it.
View Top Employees from The Compounding FacilityWebsite | http://www.thecompoundingfacility.com |
Revenue | $6 million |
Employees | View employees |
Address | 3833 Richmond Ave, Staten Island, New York 10312, US |
Phone | (718) 984-6600 |
Technologies |
JavaScript,
HTML,
ASP.NET
+4 more
(view full list)
|
Industry | Drug Stores & Pharmacies, Retail |
SIC | SIC Code 59 Companies, SIC Code 591 Companies |
NAICS | NAICS Code 44 Companies, NAICS Code 4461 Companies, NAICS Code 446 Companies |
Looking for a particular The Compounding Facility employee's phone or email?
The The Compounding Facility annual revenue was $6 million in 2024.
The Compounding Facility is based in Staten Island, New York.
The NAICS codes for The Compounding Facility are [44, 4461, 446].
The SIC codes for The Compounding Facility are [59, 591].